Literature DB >> 23018755

A case of fatal fulminant myocarditis presenting as an acute ST-segment elevation myocardial infarction and persistent ventricular tachyarrhythmia associated with influenza A (H1N1) virus in a previously healthy pregnant woman.

Mel A Ona1, Daniel R Bashari, Zubin Tharayil, Aglae Charlot, Iffath Hoskins, Michael Timoney, Shakeel Usmani, Roman Royzman.   

Abstract

Several studies have reported influenza A (H1N1) virus as a cause of fulminant myocarditis. We report the first fatal case of fulminant myocarditis presenting as an acute ST-segment elevation myocardial infarction and ventricular tachyarrhythmia associated with influenza A (H1N1) in a previously healthy pregnant woman. A 38-year-old Asian woman, gravida 3, para 1-0-1-1, presented with flu-like symptoms. Initially, she developed wide-complex tachycardia requiring several defibrillations and was later intubated. Electrocardiogram showed ST-segment elevation. Coronary angiogram was negative and a pulmonary angiogram ruled out pulmonary embolism. Fetal compromise was noted on the monitor, and the patient underwent an emergent cesarean section. She subsequently expired. Autopsy confirmed severe myocarditis. Further testing confirmed influenza A (H1N1) virus. This case of a rare, yet lethal, complication of H1N1 infection underscores the importance of increased awareness among health care professionals to provide pregnant women with vaccination and prompt treatment.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2012        PMID: 23018755     DOI: 10.1159/000342076

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  2 in total

Review 1.  Influenza pathogenicity during pregnancy in women and animal models.

Authors:  Debby van Riel; Hans-Willi Mittrücker; Geraldine Engels; Karin Klingel; Udo R Markert; Gülsah Gabriel
Journal:  Semin Immunopathol       Date:  2016-07-07       Impact factor: 9.623

Review 2.  Immune Mechanisms in Cardiovascular Diseases Associated With Viral Infection.

Authors:  Radha Gopal; Michael A Marinelli; John F Alcorn
Journal:  Front Immunol       Date:  2020-10-22       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.